Rural Caregivers’ Willingness for Community Pharmacists to Administer the HPV Vaccine to Their Age-Eligible Children

Abstract

Human papillomavirus (HPV) vaccination uptake varies by geographic regions with rural, often medically underserved areas, lagging behind more urban regions in terms of vaccine initiation and completion. In these regions, pharmacies may serve as an additional location for HPV vaccine administration. Little is known about rural caregivers’ willingness to have their HPV vaccine age-eligible children obtain this vaccine from their local pharmacist. First and second authors conducted 26 in-depth interviews with caregivers of HPV vaccine age-eligible children living in rural regions of a southwestern state to explore their perceptions of the HPV vaccine and their willingness for pharmacist-administered HPV vaccination. They analyzed interview data using an inductive qualitative content analyses approach. The majority of caregivers were unaware that pharmacists could offer adolescent vaccines. However, most were willing to allow their children to receive the vaccine from this non-traditional source. Comments related to obtaining vaccinations from pharmacists related mostly to concerns about proper training and their certification to vaccinate against HPV. Caregivers believed that having a pharmacist administer the HPV vaccine would not affect their relationship with their primary care provider. Caregivers preferred print health education resources and were interested in also receiving health information via social media to learn more about the HPV vaccine and pharmacists’ role in HPV vaccine administration. Pharmacies may serve as an additional site to increase HPV vaccine initiation and completion. Rural regions need additional health information about the HPV vaccine and pharmacists’ abilities to administer this cancer prevention resource.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst 107(6):djv086

    Article  Google Scholar 

  2. 2.

    Zahnd W, James AS, Jenkins WD, Izadi SR, Fogleman AJ, Steward DE, Colditz GA, Brard L (2017) Rural-urban differences in cancer incidence and trends in the United States. Cancer Epidemiol Biomark Prev 27:1265–1274

    Article  Google Scholar 

  3. 3.

    Centers for Disease Control and Prevention (2014) CDC grand rounds: reducing the burden of HPV-associated cancer and disease. Morb Mortal Wkly Rep 63(4):69–72

    Google Scholar 

  4. 4.

    Iversen OE, Miranda MJ, Ulied A, Soerdal T, Lazarus E, Chokephaibulkit K, Block SL, Skrivanek A, Azurah AGNF, Siew M (2016) Immunogenicity of the 9-valent HPV vaccine using 2-dose regimens in girls and boys vs a 3-dose regimen in women. JAMA 316(22):2411–2421

    CAS  Article  Google Scholar 

  5. 5.

    Meites E (2016) Use of a 2-dose schedule for human papillomavirus vaccination—updated recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 65(49):1405–1408

    Article  Google Scholar 

  6. 6.

    Walker TY, Elam-Evans LD, Singleton JA, Yankey D, Markowitz LE, Fredua B, Williams C, Meyer S, Stokley S (2017) National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. Morb Mortal Wkly Rep 66(33):874–882

    Article  Google Scholar 

  7. 7.

    Mohammed KA, Subramaniam DS, Geneus CH, Henderson ER, Dean CA, Subramaniam DP, Burroughs TE (2018) Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med 109:39–43

    Article  Google Scholar 

  8. 8.

    Boyd ED, Phillips JM, Schoenberger YM, Simpson (2018) Barriers and facilitators to HPV vaccination among rural Alabama adolescents and their caregivers. Vaccine 36(28):4126–4133

    Article  Google Scholar 

  9. 9.

    Mills LA, Head KJ, Vanderpool RC (2013) HPV vaccination among young adult women: a perspective from Appalachian Kentucky. Prev Chronic Dis 10:E17

    Article  Google Scholar 

  10. 10.

    Carhart MY, Schminkey DL, Mitchella EM, Keim-Malpass J (2018) Barriers and facilitators to improving Virginia’s HPV vaccination rate: a stakeholder analysis with implications for pediatric nurses. J Pediatr Nurs 42:1–8

    Article  Google Scholar 

  11. 11.

    Getrich CM, Broidy LM, Kleymann E, Helitzer DL, Kong AS, Sussman AL (2014) Different models of HPV vaccine decision-making among adolescent girls, parents, and health-care clinicians in New Mexico. Ethn Health 19(1):47–63

    Article  Google Scholar 

  12. 12.

    Sussman AL, Helitzer D, Bennet A, Solares A, Lanoue M, Getrich C (2015) Catching up with the HPV vaccine: challenges and opportunities in primary care. Ann Fam Med 13(4):354–360

    Article  Google Scholar 

  13. 13.

    Kepka D, Spigarelli MG, Warner EL, Yoneoka Y, McConnell N, Balch A (2016) Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data. Papillomavirus Res 2:128–132

    Article  Google Scholar 

  14. 14.

    Katz IT, Bogart LM, Fu CM, Liu Y, Cox JE, Samuels RC, Chase T, Schubert P, Schuster MA (2016) Barriers to HPV immunization among blacks and latinos: a qualitative analysis of caregivers, adolescents, and providers. BMC Public Health 16(1):874

    Article  Google Scholar 

  15. 15.

    Mclean HQ, Birchmeier B, Chow B, Vickrs E, McNeil M, Gee J, Stokley S, Belongia E, Vanwormer J (2016) Health care provider attitudes and barriers regarding human papillomavirus (HPV) vaccination: factors associated with increasing HPV vaccine coverage before and after an intervention program. Open Forum Infect Dis 3(suppl 1):718

    Article  Google Scholar 

  16. 16.

    Preciado M, Hudson SM, Rondinelli J, Glenn BA, Chao C (2015) An in-depth interview study of immunization providers to understand practice patterns, barriers and facilitators for administering the 3-dose HPV vaccine series. J Patient Cent Res Rev 2(2):90–91

    Article  Google Scholar 

  17. 17.

    US Department of Health and Human Services (2014) Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel, National Cancer Institute, Editor. 2014: Bethesda, MD. Accessed from https://deainfo.nci.nih.gov/advisory/pcp/annualreports/hpv/PDF/PCP_Annual_Report_2012-2013.pdf

  18. 18.

    Fava JP, Colleran J, Bignasci F, Cha R, Kilgore (2017) Adolescent human papillomavirus vaccination in the United States: opportunities for integrating pharmacies into the immunization neighborhood. Hum Vaccin Immunother

  19. 19.

    Nichols K, Girotto J, Mitchell-Van Steele A, Stofella S (2017) Duty to advocate: human papillomavirus vaccination. J Pediatr Pharmacol Ther 22(1):74–76

    PubMed  PubMed Central  Google Scholar 

  20. 20.

    Gallup (2018) Honesty/ethics in professions. Accessed from https://news.gallup.com/poll/1654/honesty-ethics-professions.aspx

  21. 21.

    National Association of Chain Drug Stores, 2010–2011 chain pharmacy industry profile. 2010, NACDS: Alexandria, VA

  22. 22.

    Hohmeier KC, Randolph DD, Smith CT, Hagemann TM (2016) A multimodal approach to improving human papillomavirus vaccination in a community pharmacy setting. SAGE Open Med 4:1–5

    Article  Google Scholar 

  23. 23.

    Goad J, Bach A (2015) The role of community pharmacy-based vaccination in the USA: current practice and future directions. Integr Pharm Res Pract 4:67–77

    PubMed  PubMed Central  Google Scholar 

  24. 24.

    Shah PD, Trogdon JG, Golden SD, Golin CE, Marciniak MW, Brewer NT (2018) Impact of pharmacists on access to vaccine providers: a geospatial analysis. Milbank Q 96(3):568–592

    Article  Google Scholar 

  25. 25.

    McIntosh J, Sturpe D, Khanna N (2008) Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. J Am Pharm Assoc 48(1):e1–e16

    Article  Google Scholar 

  26. 26.

    Rothholz M, Tan L (2017) Promoting the immunization neighborhood: benefits and challenges of pharmacies as additional locations for HPV vaccination. Hum Vaccin Immunother 13(8):1856–1858

    Article  Google Scholar 

  27. 27.

    Kuper A, Reeves S, Levinson W (2008) An introduction to reading and appraising qualitative research. BMJ 337(7666):404–407

    Google Scholar 

  28. 28.

    Lombard M, Snyder-Duch J, Bracken CC (2010) Practical resources for assessing and reporting intercoder reliability in content analysis research projects. Accessed from http://matthewlombard.com/reliability/index_print.html#What%20is%20intercoder%20reliability

    Google Scholar 

  29. 29.

    Sutton J, Austin Z (2015) Qualitative research: data collection, analysis, and management. Can J Hop Pharm 68(3):226–231

    Google Scholar 

  30. 30.

    Ando H, Cousins R, Young C (2014) Achieving saturation in thematic analysis: development and refinement of a codebook. Compr Psychol 3:4

    Article  Google Scholar 

  31. 31.

    Islam JY, Gruber JF, Lockhart A, Kunwar M, Wilson S, Smith SB, Brewer NT, Smith JS (2017) Opportunities and challenges of adolescent and adult vaccination administration within pharmacies in the United States. Biomed Inform Insights 9:1178222617692538

    Article  Google Scholar 

  32. 32.

    Shah P, Calo WA, Marciniak MW, Gilkey MB, Brewer N (2018) Support for pharmacist-provided HPV vaccination: national surveys of US physicians and parents. Cancer Epidemiol Biomark Prev 27(8):970–978

    Article  Google Scholar 

  33. 33.

    Arizona State Legislature, A.S., 32-1974. Pharmacists’ administration of immunizations, vaccines and emergency medications; certification; reporting requirements; advisory committee; definitions. 2007. Accessed from https://www.azleg.gov/viewDocument/?docName=http://www.azleg.gov/ars/32/01974.htm

  34. 34.

    Swiecki-Sikora AL, Henry KA, Kepka D (2019) HPV vaccination coverage among US teens across the rural-urban continuum. J Rural Health. https://doi.org/10.1111/jrh.12353

  35. 35.

    Goad JA, Taitel MS, Fensterheim LE, Cannon AE (2013) Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med 11(5):429–436

    Article  Google Scholar 

  36. 36.

    Rock C, de Barra E, Sadlier C, Kelly S, Dowling C, McNally C, Bergin C (2013) Impact of a new vaccine clinic on hepatitis B vaccine completion and immunological response rates in an HIV-positive cohort. J Infect Public Health 6(3):173–178

    Article  Google Scholar 

  37. 37.

    Van Dyne EA, Jnley SJ, Saraiya M, Thomas CC, Markowtiz LE, Benard VB (2018) Trends in human papillomavirus–associated cancers—United States, 1999–2015. Morb Mortal Wkly Rep 67(33):918–924

    Article  Google Scholar 

  38. 38.

    DeStefano F, Bodenstab HM, Offit PA (2019) Principal controversies in vaccine safety in the United States. Clin Infect Dis ciz135, https://doi-org.ezproxy1.lib.asu.edu/10.1093/cid/ciz135

  39. 39.

    Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis R, Markowitz L (2014) Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014—United States. Morb Mortal Wkly Rep 63(29):620–624

    Google Scholar 

  40. 40.

    Kata A (2002) Anti-vaccine activists, Web 2.0, and the postmodern paradigm—an overview of tactics and tropes used online by the anti-vaccination movement. Vaccine 30(25):3778–3789

    Article  Google Scholar 

  41. 41.

    Pías-Peleteiro L, Cortés-Bordoy J, Martinón-Torres F (2013) Dr Google: what about the human papillomavirus vaccine? Hum Vaccin Immunother 9(8):1712–1719

    Article  Google Scholar 

  42. 42.

    Dilley SE, Peral S, Straugh M, Scarinci I (2018) The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med 113:124–131

    Article  Google Scholar 

  43. 43.

    Kepka D, Bodson J, Lai D, Sanchez-Birkead AS, Villalta J, Mukundente V, Tavake-Psi F, Davis FA, Lee D, Napia E, Mooney R, Coulter H, Stark LA (2018) Factors associated with human papillomavirus vaccination among diverse adolescents in a region with low human papillomavirus vaccination rates. Health Equity 2(1):223–232

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alexis M. Koskan.

Ethics declarations

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Arizona State University Institutional Review Board, STUDY00006995) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Koskan, A.M., Dominick, L.N. & Helitzer, D.L. Rural Caregivers’ Willingness for Community Pharmacists to Administer the HPV Vaccine to Their Age-Eligible Children. J Canc Educ 36, 189–198 (2021). https://doi.org/10.1007/s13187-019-01617-z

Download citation

Keywords

  • Human papillomavirus
  • HPV vaccine
  • Primary care
  • Pharmacy
  • Rural